Have to add more here mate, for 'doubles' the efficacy when comparing with Keytruda mono, that is the NSCLC case. In head and neck cohort, this type is so much harder and EFTI combo is trippling compare to Keytruda mono, plus the duration of responding (convert to the quality of response) is even greater extent.
- Forums
- ASX - By Stock
- IMM
- Overnight Market report
Overnight Market report, page-1484
-
- There are more pages in this discussion • 1,359 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 39.5¢ | $1.158M | 2.895M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 205303 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 175090 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 205303 | 0.395 |
6 | 96813 | 0.390 |
7 | 107764 | 0.385 |
13 | 260356 | 0.380 |
2 | 27800 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 175090 | 17 |
0.405 | 175504 | 12 |
0.410 | 403068 | 20 |
0.415 | 304295 | 13 |
0.420 | 502644 | 9 |
Last trade - 15.43pm 11/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |